E
Eric Zomawia
Publications - 28
Citations - 1107
Eric Zomawia is an academic researcher. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 15, co-authored 23 publications receiving 838 citations.
Papers
More filters
Journal ArticleDOI
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016
Preet K Dhillon,Prashant Mathur,A Nandakumar,Christina Fitzmaurice,G Anil Kumar,Ravi Mehrotra,Deepak Kumar Shukla,Goura Kishor Rath,Prakash C. Gupta,Rajaraman Swaminathan,JS Thakur,Subhojit Dey,Christine A. Allen,Rajendra A. Badwe,Rajesh Dikshit,R S Dhaliwal,Tanvir Kaur,Amal C Kataki,Rudrapatna N Visweswara,P Gangadharan,Eliza Dutta,Melissa Furtado,Chris M Varghese,Deeksha Bhardwaj,P. M. Muraleedharan,Christopher M Odell,Scott D Glenn,Manjit S Bal,P P Bapsy,James R Bennett,Vijay K Bodal,Joy K Chakma,Sekhar Chakravarty,Meesha Chaturvedi,Priyanka Das,Vinay Deshmane,Nitin Gangane,James Harvey,P Jayalekshmi,Kaling Jerang,Sarah Charlotte Johnson,Pramod Kumar Julka,Debnath Kaushik,Vinotsole Khamo,Shravani Koyande,Michael Kutz,W B Langstieh,K B Lingegowda,R C Mahajan,Jagadish Mahanta,Gautam Majumdar,Natesan Manoharan,Aleyamma Mathew,Bhagwan M. Nene,Sanghamitra Pati,Prasanta Pradhan,Vinod Raina,Ranganathan Rama,C Ramesh,Krishnan Sathishkumar,Kathryn Schelonka,P Sebastian,Katya Anne Shackelford,Janmesh Shah,Viswanathan Shanta,Jagannath D Sharma,Atul Shrivastava,Sopai Tawsik,Brij B Tyagi,K Vaitheeswaran,Elizabeth Vallikad,Yogesh Verma,Eric Zomawia,Stephen S Lim,Theo Vos,Rakhi Dandona,K. Srinath Reddy,Mohsen Naghavi,Christopher J L Murray,Soumya Swaminathan,Lalit Dandona +80 more
TL;DR: The substantial heterogeneity in the state-level incidence rate and health loss trends of the different types of cancer in India over this 26-year period should be taken into account to strengthen infrastructure and human resources for cancer prevention and control at both the national and state levels.
Journal ArticleDOI
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
Rengaswamy Sankaranarayanan,Priya R. Prabhu,Michael Pawlita,Tarik Gheit,Neerja Bhatla,Richard Muwonge,Bhagwan M. Nene,Pulikottil Okuru Esmy,Smita Joshi,Usha Rani Reddy Poli,Parimal Jivarajani,Yogesh Verma,Eric Zomawia,Maqsood Siddiqi,Surendra S Shastri,Kasturi Jayant,Sylla G. Malvi,Eric Lucas,Angelika Michel,Julia Butt,Janki Mohan Babu Vijayamma,Subha Sankaran,Thiraviam Pillai Rameshwari Ammal Kannan,Rintu Varghese,Uma Divate,Shila Thomas,Geeta Joshi,Martina Willhauck-Fleckenstein,Tim Waterboer,Martin Müller,Peter Sehr,Sanjay Hingmire,Alka Kriplani,Gauravi A Mishra,Sharmila Pimple,Radhika Jadhav,Catherine Sauvaget,Massimo Tommasino,Madhavan Radhakrishna Pillai +38 more
TL;DR: Despite the limitations imposed by the suspension of the HPV vaccination, the findings lend support to the WHO recommendation of two doses, at least 6 months apart, for routine vaccination of young girls.
Journal ArticleDOI
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.
Rengaswamy Sankaranarayanan,Smita Joshi,Richard Muwonge,Pulikottil O. Esmy,Partha Basu,Priya R. Prabhu,Neerja Bhatla,Bhagwan M. Nene,Janmesh Shaw,Usha Rani Reddy Poli,Yogesh Verma,Eric Zomawia,Sharmila Pimple,Massimo Tommasino,Michael Pawlita,Tarik Gheit,Tim Waterboer,Peter Sehr,Madhavan Radhakrishna Pillai +18 more
TL;DR: It is indicated that a single dose of quadrivalent HPV vaccine is immunogenic and provides lasting protection against HPV 16 and 18 infections similar to the three- and two-dose vaccine schedules, although the study suffer from some limitations.
Journal ArticleDOI
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study.
Partha Basu,Sylla G. Malvi,Smita Joshi,Neerja Bhatla,Richard Muwonge,Eric Lucas,Yogesh Verma,Pulikkottil Okkuru Esmy,Usha Rani Reddy Poli,Anand Shah,Eric Zomawia,Sharmila Pimple,Kasturi Jayant,Sanjay Hingmire,Aruna Chiwate,Uma Divate,Shachi Vashist,Gauravi A Mishra,Radhika Jadhav,Maqsood Siddiqi,Subha Sankaran,Priya R. Prabhu,Thiraviam Pillai Rameshwari Ammal Kannan,Rintu Varghese,Surendra S Shastri,Devasena Anantharaman,Tarik Gheit,Massimo Tommasino,Catherine Sauvaget,M. Radhakrishna Pillai,Rengaswamy Sankaranarayanan +30 more
TL;DR: In this article, the authors compared the vaccine efficacy of single dose to that of three and two doses in protecting against persistent HPV 16 and 18 infection at 10 years post vaccination, and concluded that a single dose of vaccine provides similar protection against persistent infection from HPV 16, the genotypes responsible for nearly 70% of cervical cancers, to that provided by two or three doses.
Journal ArticleDOI
Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer.
Rakhshan Ihsan,Pradeep Singh Chauhan,Ashwani Kumar Mishra,Dhirendra Singh Yadav,Mishi Kaushal,Jagannath Dev Sharma,Eric Zomawia,Yogesh Verma,Sujala Kapur,Sunita Saxena +9 more
TL;DR: These results identified distinct gene-gene and gene environment interactions in smokers and non-smokers, which confirms the importance of multifactorial interaction in risk assessment of lung cancer.